Helix Acquisition Corp.
Status: Deal Closed
U=S
| IPO Proceeds, $M | $115.00M |
|---|---|
| IPO Date | Oct 20, 2020 |
| CEO | Bihua Chen |
| Left Lead | Jefferies |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector |
Healthcare
Healthcare and healthcare related industries |
| IPO Geography | Global |
| Target Company | MoonLake Immunotherapeutics AG |
| Deal Announced | Oct 4, 2021 |
| Deal Size, $M | $360.00M |
| Deal Sector | Healthcare |
| Deal Geography | Europe |
| SEC Filings | www.sec.gov |
| Approval Vote | Mar 31, 2022 |
| Amendment Vote | TBD |
| Closing Date | Apr 5, 2022 |
Formerly HLXA
MLTX
| Price | $49.82 |
|---|---|
| Last closing price | $49.33 |
| H/L, today | $48.97 / $50.98 |
| H/L, 52-week | $7.05 / $63.40 |
| Volume, today | 191,049 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Helix Acquisition Corp.:
- Structure and cap table
- 5 directors & officers
- 26 filings and events
- 1 underwriters
- 5 deal advisors
- 6 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Bihua Chen | 52 | CEO and Chairman |
| Jay Scollins | 46 | CFO |
| Nancy Chang | 70 | Director |
| Will Lewis | 51 | Director |
| John Schmid | 57 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Jefferies | BR | 10,000,000 | units |
| 10,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.